0 likes | 1 Vues
The dexrazoxane market was valued at USD 887.7 million in 2025 and is projected to reach USD 1,502 million by 2035, growing at a CAGR of 5.4% during the forecast period (2026u20132035). The marketu2019s growth is driven by the increasing use of dexrazoxane in oncology for preventing cardiotoxicity caused by anthracycline-based chemotherapy, especially in patients with breast cancer, leukemia, and lymphoma. With rising global cancer prevalence and growing awareness of drug safety and supportive oncology care, the demand for dexrazoxane continues to strengthen across hospitals and specialty cancer treat
E N D